Target intelligence / Profile preview

Reactive oxygen species and lipid-derived radicals (ROS/LDR)

Target
ROS/LDR
Molecular classification
Reactive molecules, Free radicals, Oxidants, Other
01

Overview

Reactive oxygen species (ROS) and lipid-derived radicals are highly reactive chemical species formed as natural byproducts of oxygen metabolism and lipid peroxidation. While they play essential roles in cell signaling and the immune response at low concentrations, an imbalance between their production and the body's antioxidant defenses leads to oxidative stress. This state causes significant damage to cellular components, including DNA, proteins, and membrane lipids, contributing to the pathogenesis of numerous conditions such as neurodegenerative diseases, cardiovascular disorders, and cancer (Source: NIH, PubMed). In a therapeutic context, these molecules are targeted by antioxidants and radical scavengers designed to neutralize them before they can cause irreversible cellular damage. Drugs like edaravone and N-acetylcysteine act by directly reacting with these species or by boosting endogenous antioxidant systems like glutathione. However, targeting ROS is challenging because complete suppression can interfere with vital physiological processes, such as the oxidative burst used by white blood cells to kill pathogens (Source: StatPearls, Wikipedia).

Other names
ROSLipid radicalsReactive oxygen speciesLipid peroxyl radicalsSuperoxideHydroxyl radicalHydrogen peroxideSinglet oxygenLipid hydroperoxides
02

Mechanism of action

Direct scavenging of free radicals, neutralization of reactive oxygen species, and inhibition of lipid peroxidation chain reactions.

03

Biological functions

Signal transductionImmune responseApoptosisCell proliferationRedox homeostasisOxidative stress induction
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseIschemia-reperfusion injuryAging
05

Safety considerations

Interference with essential physiological redox signalingPotential pro-oxidant effects at high concentrationsPoor bioavailability of many antioxidant compoundsLack of specificity in targeting particular radical species
06

Interacting drugs

Edaravone

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-Oxo-2'-deoxyguanosine (8-OHdG)F2-isoprostanes4-Hydroxynonenal (4-HNE)Protein carbonyls

Beyond the preview

Go deeper on Reactive oxygen species and lipid-derived radicals (ROS/LDR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and lipid-derived radicals (ROS/LDR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call